AZN

AZN Free Cash Flow

$8.74BTTM · USD

Period ending:

AZN FY Free Cash FlowUSD
AZN FY Free Cash Flow1990-12-31: $266.19M1991-12-31: $119.76M1992-12-31: -$200.20M1993-12-31: $242.59M1994-12-31: $132.89M1995-12-31: $154.52M1996-12-31: $148.99M1997-12-31: -$8.27M1998-12-31: $34.86M1999-12-31: -$1.84B2000-12-31: $875.25M2001-12-31: $443.83M2002-12-31: $3.49B2003-12-31: $2.13B2004-12-31: $4.54B2005-12-31: $5.76B2006-12-31: $6.35B2007-12-31: $5.83B2008-12-31: $4.70B2009-12-31: $8.78B2010-12-31: $8.26B2011-12-31: $6.52B2012-12-31: $2.33B2013-12-31: $5.34B2014-12-31: $4.31B2015-12-31: $536.00M2016-12-31: $1.83B2017-12-31: $1.96B2018-12-31: $1.25B2019-12-31: $509.00M2020-12-31: $2.19B2021-12-31: $3.76B2022-12-31: $7.24B2023-12-31: $6.57B2024-12-31: $7.28B2025-12-31: $8.67B$8.78B-$1.84B
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AZN free cash flow history

Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

AstraZeneca PLC Ordinary Shares Free Cash Flow — Annual fiscal periods (USD)
Period endingFree Cash Flow (USD)
8,670,000,000
7,275,000,000
6,567,000,000
7,237,000,000
3,763,000,000
2,193,000,000
509,000,000
1,247,000,000
1,958,000,000
1,831,000,000
536,000,000
4,306,000,000
5,342,000,000
2,329,000,000
6,524,000,000
8,260,000,000
8,782,000,000
4,703,000,000
5,831,000,000
6,354,000,000
5,764,000,000
4,541,000,000
2,134,000,000
3,493,000,000
443,826,976
875,253,912
-1,843,094,022
34,857,664
-8,265,556
148,987,909
154,521,292
132,889,326
242,589,195
-200,203,237
119,755,997
266,193,433

Compare free cash flow

Other companies in —. Each page shows its own reporting periods and currency.

All AZN financial metrics · AZN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.